Purpose: Periorbital myxedema is one the most challenging symptoms for patients with Graves' eye disease (GED). The treatment of this condition is complex and often unsatisfactory. This case demonstrates the use of intralesional hyaluronidase to treat cosmetically concerning periorbital myxedema.
Observations: Follow up showed no clinically significant recurrence of myxedema over one year.
Conclusion: Intralesional hyaluronidase represented an effective and safe treatment of periorbital myxedema in a patient with Graves' eye disease.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262547 | PMC |
| http://dx.doi.org/10.1016/j.ajoc.2020.100751 | DOI Listing |
Publication Analysis
Top Keywords
periorbital myxedema
12
intralesional hyaluronidase
12
graves' eye
8
eye disease
8
periorbital
4
myxedema treated
4
treated intralesional
4
hyaluronidase purpose
4
purpose periorbital
4
myxedema challenging
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!